![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0877.jpg)
/
Published illustration
of pancreatic SBRT:
No (obvious) safety margin:
• Imaging for extension of diease?
• Microscopic disease?
• Residual uncertainties?
Despite small (zero) safety margin:
• Full dose to adjacant duodenal
wall
• Relevant doses to intestine
ESTRO SBRT Course 2015 - Emerging SBRT indications
8
Pancreatic cancer